Literature DB >> 17923812

A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer.

R James Barnard1, Pak Shan Leung, William J Aronson, Pinchas Cohen, Lawrence A Golding.   

Abstract

Epidemiological studies report that regular physical activity can reduce the risk for prostate cancer. This study was conducted to investigate possible mechanisms to explain the epidemiological data. Serum from sedentary controls or men with regular (5 days/week) aerobic exercise was used to stimulate lymph node cancer of the prostate (LNCaP) tumor cells in vitro. Growth and apoptosis were assessed and cell lysate p53, p21 and Bcl-2 proteins measured. Tryphostin was used to block the insulin-like growth factor-I receptor. Exercise serum-stimulated growth was reduced at 2 and 4 days while apoptosis was increased. Tryphostin reduced growth in the control but not in the exercise serum-stimulated samples. Total cell lysate p53 protein was higher in the exercise serum-stimulated cells at both 2 and 4 days. The levels of p21 protein, a downstream effector of p53, were elevated at 2 days but were normal at 4 days. Bcl-2, an antiapoptotic protein, was significantly reduced at 2 days in the exercise serum-stimulated lysates. These results indicate that exercise training alters serum insulin-like growth factor axis factors in vivo that increase LNCaP cellular p53 protein content in vitro leading to reduced growth via p21 and induced apoptosis via the mitochondrial pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923812     DOI: 10.1097/01.cej.0000243851.66985.e4

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  18 in total

Review 1.  Potential for prostate cancer prevention through physical activity.

Authors:  Stacey Young-McCaughan
Journal:  World J Urol       Date:  2011-12-24       Impact factor: 4.226

Review 2.  Physical activity and its mechanistic effects on prostate cancer.

Authors:  A Wekesa; M Harrison; R W Watson
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-03-24       Impact factor: 5.554

3.  Relationship Between Aerobic Fitness, the Serum IGF-1 Profiles of Healthy Young Adult African American Males, and Growth of Prostate Cancer Cells.

Authors:  Rajagopalan Sridhar; Vernon Bond; Jacquelyn Dunmore-Griffith; Valerie M Cousins; Renshu Zhang; Richard M Millis
Journal:  Am J Mens Health       Date:  2016-06-22

Review 4.  Physical Activity and Prostate Cancer: An Updated Review.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2017-06       Impact factor: 11.136

Review 5.  Lack of exercise is a major cause of chronic diseases.

Authors:  Frank W Booth; Christian K Roberts; Matthew J Laye
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

Review 6.  Exercise in prevention and management of cancer.

Authors:  Robert U Newton; Daniel A Galvão
Journal:  Curr Treat Options Oncol       Date:  2008-08-13

7.  Lifetime total physical activity and prostate cancer risk: a population-based case-control study in Sweden.

Authors:  Fredrik Wiklund; Ylva Trolle Lageros; Ellen Chang; Katarina Bälter; Jan-Erik Johansson; Hans-Olov Adami; Henrik Grönberg
Journal:  Eur J Epidemiol       Date:  2008-10-18       Impact factor: 8.082

Review 8.  Weight control and cancer preventive mechanisms: role of insulin growth factor-1-mediated signaling pathways.

Authors:  Linglin Xie; Weiqun Wang
Journal:  Exp Biol Med (Maywood)       Date:  2013-02

Review 9.  Mitochondrial biology and prostate cancer ethnic disparity.

Authors:  Jialin Xiao; Pinchas Cohen; Mariana Carla Stern; Folakemi Odedina; John Carpten; Renee Reams
Journal:  Carcinogenesis       Date:  2018-12-13       Impact factor: 4.944

10.  Early-Life Cardiorespiratory Fitness and Long-term Risk of Prostate Cancer.

Authors:  Weiva Sieh; Kristina Sundquist; Casey Crump; Pär Stattin; James D Brooks; Tanja Stocks; Jan Sundquist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-08-20       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.